The RNA lariat debranching enzyme, Dbr1, is a metallophosphoesterase that cleaves 2 0 -5 0 phosphodiester bonds within intronic lariats. 
, and Zn 2+ . While in initial structures of the Entamoeba histolytica Dbr1 only one of the two catalytic metal-binding sites were observed to be occupied (with a Mn 2+ ion), recent structures determined a Zn 2+ /Fe 2+ heterobinucleation. We solved a high-resolution X-ray crystal structure (1.8 A) of the E. histolytica Dbr1 and determined a Zn 2+ / Mn 2+ occupancy. ICP-AES corroborate this finding, and in vitro debranching assays with fluorescently labeled branched substrates confirm activity.
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Lariats are the natural by-products of Group II and spliceosomal introns [1] [2] [3] and form when the 5 0 end of an intron is ligated to the 2 0 hydroxyl of an internal adenosine branchpoint during splicing. The discovery of embedded miRNA and snoRNA sequences within intronic lariats [4] [5] [6] conferred to them a critical role in the generation of such regulatory molecules with the potential to affect numerous downstream cellular processes.
The 2 0 -5 0 phosphoesterase (debranching) activity catalyzed by the RNA lariat debranching enzyme, Dbr1, was first discovered within HeLa cells when excised intronic lariats were linearized upon nuclear extract incubations [2] . The DBR1 gene was discovered when a genetic screen for cellular factors required for yeast Ty1 retrotransposition revealed a deletion that resulted in a phenotype of reduced retrotransposition and accumulation of intronic RNA lariats [7] .
While the DBR1 gene is nonessential in lower eukaryotes [7] , it has been speculated that this is due to comparatively low numbers of introns in such organisms. dbr1 À strains of Saccharomyces cerevisiae (which contain~255 introns [8] ) and Schizosaccharomyces pombe (~4730 introns [9] ) demonstrate a phenotype of accumulated lariats while mutants of the latter also demonstrate severe growth defects and aberrant cell morphology [10] . Caenorhabditis elegans and Drosophila Melanogaster dbr1 À mutants demonstrate partial lethality, slow growth and/or sterility [11] (WormBase). Dbr1 was required for HIV-1 propagation in a human osteosarcoma (HOS) cell line, the replication of which mimics retroelement replication Abbreviations ALS, amyotrophic lateral sclerosis; CTD, carboxy-terminal domain; EhDbr1, Entamoeba histolytica RNA lariat debranching enzyme 1; GFB, gel filtration buffer; HOS, human osteosarcoma; ICP-AES, inductively couple plasma atomic emission spectroscopy; MPE, metallophosphoesterase; NSLS, National Synchrotron Light Source; SEC, size exclusion chromatography. [12, 13] . Finally, siRNA knockdown of Dbr1 rescues TDP-43 toxicity (pertinent to amyotrophic lateral sclerosis (ALS)) in a human M17 neuroblastoma cell line and in rat primary cortical neurons-substantiating Dbr1 as potential therapeutic target in the treatment of neurodegenerative diseases [14] . Dbr1 belongs to the phosphoesterase superfamily of enzymes that includes Mre11, due to the presence of three signature motifs of the class, namely: DIH-(X 25 )-GDYVDR-(X 27 )-GNHE [15, 16] . This assignment was corroborated by structure-function analyses as mutation of several putative catalytic residues within the aforementioned motifs resulted in lariat accumulation in vivo and decreased or abolished debranching activity in vitro [17] . Based on homology modeling and residue conservation, the binuclear active site observed in Mre11, in which catalytic residues coordinate two Mn 2+ ions [15] , had been proposed to also exist within Dbr1. Curiously, the first crystal structures of Dbr1 identified Mn 2+ in only one of the metal-binding sites, while the other site was vacant [18] . Recent cocrystal structures solved by the same group, however, indicated a Zn 2+ /Fe 2+ heterobinucleation and in vitro debranching assays determined this metal composition was optimally active [19] .
Here, we present an X-ray crystal structure of the Entamoeba histolytica RNA lariat debranching enzyme 1 (EhDbr1) to a maximum resolution of 1.8
A. Our structure model indicates a novel heterobinucleation consisting of one Mn 2+ ion and one Zn 2+ ion. Inductively couple plasma atomic emission spectroscopy (ICP-AES) determined that purified EhDbr1 exists in primarily two states-one that is heteronucleated with Zn 2+ and Mn 2+ and the other that is homonucleated with Zn 2+ . In vitro debranching assays determined this mixed sample is comparably active to previously characterized EhDbr1 samples that contain different metal configurations. These results expand upon metal composition characterizations for EhDbr1 and are consistent with the diverse metal configurations that are occasional features of this class of enzymes.
Materials and methods

EhDbr1 construct cloning
The EhDBR1 cDNA, optimized for Escherichia coli expression, was purchased from DNA 2.0, Inc. (Now ATUM, Newark, CA, USA) and was cloned from pJ204 into pET22b(+) by PCR amplifying the gene with flanking BamHI and XhoI restriction sites. The pET22b(+)-EhDbr1 construct was generated by completing appropriate restriction enzyme digestions and T4 Ligase ligation reactions. To improve diffraction, the first six residues were removed via Quick change site-directed mutagenesis generating EhDbr1 (D1-6). All constructs were designed to incorporate a fused, upstream His-12 tag separated from the EhDbr1 cDNA by a TEV protease recognition sequence that facilitates subsequent purification and crystallization.
Expression and purification of recombinant EhDbr1
Bacterial expression cultures were initiated from single colonies of BL21(pRARE) E. coli, transformed with pET22b(+) EhDbr1 and plated on LB ampicillin/chloramphenicol. Single colonies were picked and grown in 5 mL of LB with 50 lgÁmL À1 ampicillin and 25 lgÁmL À1 chloramphenicol, for 16-18 h at 37°C. Starter cultures were used to inoculate 500 mL of LB (with 50 lgÁmL À1 ampicillin and 25 lgÁmL À1 chloramphenicol) and cultures were grown at 37°C to an OD of 0.8-1.0. For induction, cultures were chilled on ice for 15 min before the addition of IPTG (1 mM) and ethanol (0.5%), and subsequently grown at 17°C overnight. Cells were harvested via centrifugation (10 min at 10 000 g) approximately 18-20 h after IPTG induction, lysed in Buffer A (20 mM Tris, pH 8.0, 5% glycerol, 1 mM b-mercaptoethanol, 750 mM NaCl, 45 mM Imidazole, 1 mM MnCl 2 ) by high-pressure homogenization and cellular debris was removed via ultracentrifugation (45 min at 30 000 g). Clarified cell lysate was batch-bound to Ninitrilotriacetic acid agarose beads then subjected to affinity column chromatography. The resin was washed with Buffer A and His-tagged EhDbr1 was eluted from the Ninitrilotriacetic acid column with Elution buffer (Buffer A with 400 mM Imidazole and 100 mM NaCl). Column fractions were analyzed by SDS/PAGE and Coomassie Brilliant Blue staining (EhDbr1 is~41 kDa) and elution fractions containing EhDbr1 were pooled and subjected to heparin sepharose chromatography. EhDbr1 was eluted from the heparin column using a gradient of low concentration of NaCl (20 mM Tris, pH 8.0, 5% glycerol, 1 mM b-mercaptoethanol, 100 mM NaCl) to high concentration of NaCl (20 mM Tris, pH 8.0, 5% glycerol, 1 mM b-mercaptoethanol, 1 M NaCl) buffers. Fractions were analyzed by SDS/PAGE and those containing EhDbr1 were pooled and dialyzed in dialysis buffer (20 mM Tris, pH 8.0, 5% glycerol, 1 mM b-mercaptoethanol, 200 mM NaCl, 25 mM Imidazole) with TEV protease for 4 h at 22°C and overnight at 4°C.
The TEV protease-treated samples were then bound to equilibrated Ni-nitrilotriacetic acid agarose beads and subjected to nonaffinity column chromatography utilizing Buffer A to wash off TEV-cleaved protein. Flow-through and wash fractions containing EhDbr1 were pooled and concentrated for size exclusion chromatography (SEC). SEC was completed using a HiLoad 16/600 S200 PG column (GE Healthcare Life Sciences, Chicago, IL, USA) and gel filtration buffer (GFB) (20 
Crystallization of EhDbr1(D1-6)
Crystal screens with purified EhDbr1 and EhDbr1(D1-6) were completed using the sitting-drop crystal screening method with Hampton Research and Qiagen screening suites. An Art Robbins Crystal Phoenix robot was used for initial screening. Preliminary crystal hits found to support microcrystal growth were replicated and optimized by manually screening various conditions. Conditions that supported high-resolution diffracting crystals were 24% PEG 8000, 0.1 M HEPES, pH 7.5, and 5 mgÁmL À1 EhDbr1(D1-6), 4°C. Cryo-protected crystals were grown in the crystallization condition with the addition of 10-20% glycerol. Crystals were initially screened at the University of Pittsburgh X-ray facility using a Saturn Kappa CCD detector and a Cu-K a rotating anode X-ray source. Crystals of sufficient quality were sent to Beamline X-25 at the National Synchrotron Light Source (NSLS) for single-wavelength anomalous dispersion data collection using X-rays of 1.1 A wavelength. Diffraction data were integrated and scaled using HKL2000 [20] and the metal ions were located using SHELXD [21] . Density modification and solvent flattening was performed using RESOLVE [22] as implemented in the PHENIX [23] crystallographic software package. Manual building of the protein model was performed using COOT [24] and the model was refined using REFMAC5 [25] as implemented with the CCP4I suite of crystallographic software [26] .
To differentiate between the anomalous scattering contributions of the Mn 2+ and Zn 2+ , diffraction data from a second crystal were collected using X-rays with wavelengths of 1.28 A (at the absorption peak of Zn) and 1. 
Debranching assays and kinetic characterizations
All debranching assays were completed in 50 mM Tris, pH 7.5, 25 mM NaCl, 2.5 mM DTT, 0.01% BSA in 10 lL reactions with 1 lM each of purified EhDbr1 and Dy547-labeled branched RNA substrate. EhDbr1 reactions were initiated with the addition of EhDbr1 to reaction mix, incubated at 30°C and stopped with 90% formamide/10% EDTA, pH 8.0 at appropriate time points. Stopped reactions were electrophoresed at 250 volts in gels containing 20% (19 : 1) polyacrylamide: bisacrylamide and 7 M urea. Substrate and product bands were quantified using a GE Typhoon FLA 9000 imager.
Results
Overview of EhDbr1 structure
X-ray data collection and refinement statistics are reported in Table 1 . EhDbr1 crystallized in a P2 1 ions present within each protein molecule in the crystal. The structure model was refined to an R work /R free of 0.17/0.21. The high-resolution structure excludes residues 1-6 of the native protein, and contains three non-native glycine residues as cloning artifacts before glutamine at position 7.
The X-ray structure we determined is nearly identical to the most recent apo-enzyme structure PDB: 5K73, with an RMSD over 349 residues of 0.424 for backbone atoms. Briefly, the EhDbr1 amino-terminal domain (NTD) (residues 7-272), features a globular, metallophosphoesterase (MPE) fold composed of two b-sheets (12 b-strands in a mixed parallel and antiparallel conformation) that creates a central b-sandwich surrounded by 12 a-helices (Fig. 1A) . The carboxyterminal domain (CTD) (residues 273-354), which is not conserved among Mre11 proteins, is helical and is located on the posterior of the protein, opposite the active site (Fig. 1A) .
Our structure reveals active site features that are consistent with the previously determined structures [18, 19] . Namely, residues His16, Asp45, Asn90, His180, His230 and His232 directly coordinate two metal ion-binding sites and have conserved counterparts with Mre11 proteins. Superposition of the active site of our structure model with the active site of the Clark et al. [19] model, demonstrates the similar coordinations of both metal-binding sites (Fig. 1B ). An otherwise invariant catalytic aspartic acid residue within the Mre11 superfamily [27] has been evolutionarily mutated to a cysteine. This cysteine mutation is present in EhDbr1 proteins and participates in the coordination of the a-site metal, in place of the aspartic acid found in Mre11. To determine the metal ion composition of the EhDbr1 active site, we collected and compared diffraction data generated from irradiation using X-rays tuned to different wavelengths. Anomalous difference maps generated from data collected at k = 1.28 A, revealed density at both metal-binding sites, whereas anomalous difference maps from data collected at k = 1.3 A, only revealed density within the b-site (Fig. 1C,D) . Given the absorption edges of Mn 2+ and Zn 2+ ions are k = 1.8961
A (keV = 6.5390) and k = 1.2837 A (keV = 9.6586), respectively, and that the previously mentioned ICP-AES analyses determined stoichiometric amounts of both ions in our sample, we determined that Mn 2+ resides within the b-site and Zn 2+ within the a-site. The data do not preclude a Zn 2+ from occupying the b-site, however, in this instance, Zn 2+ is not contributing to the observed b-site density. In our model, Asp45, Asn90, His180, His230, and the nucleophilic hydroxyl ion coordinate the Mn 2+ ion in a trigonal bipyramidal configuration while Cys14, His16, His232 and the same hydroxyl coordinate the Zn 2+ ion in a tetrahedral geometry (Fig. 1C,D) . 0 -terminal Dylight 547 (Dy547; a Cy3 equivalent) fluorescent dye and a 6-nucleotide branch linked at the 2 0 -hydroxyl of the branch point adenosine ( Fig. 2A) . Debranching reactions were initiated by mixing EhDbr1 with the RNA substrate in reaction conditions [50 mM Tris-HCl (pH = 7.5) buffer with 25 mM NaCl, 2.5 mM DTT and 0.01% BSA] with and without supplemented 1 mM Mn 2+ and were stopped at indicated time points with formamide before separation via denaturing PAGE.
With equal concentrations of EhDbr1 and substrate (1 lM each), the substrate was cleaved to 96% completion in 5 min in the presence of 1 mM Mn 2+ , while in the absence of added Mn 2+ , the substrate was to 88% (Fig. 2B,C (Fig. 2C ).
Discussion
Here, we present the X-ray crystal structure of the E. histolytica Dbr1 (refined to 1. [19] . Differences in the enzyme preparations and/or substrates may account for this discrepancy. Additionally, the metal enrichment that we observe may be catalytically suboptimal to the Fe 2+ /Zn 2+ that is observed in the EhDbr1 sample from Clark et al. [19] . The metal configuration in our model incorporates singular aspects of each of the two previous structure models, as the first reported structures identified a b-site Mn 2+ occupancy (and vacant a-site) and subsequent models identified Zn 2+ in the a-site (although Fe   2+ was present in the b-site) [18, 19] . The apparent flexible metal-binding behavior of EhDbr1 is unsurprising given that the enzyme was determined to be active in the presence of Mn 2+ , Mg
2+
, and Ni 2+ [17] , and additionally, Fe 2+ and Zn 2+ [19] . Furthermore, several MPE enzymes of the MRE11 family have been shown to be active in the presence of diverse metals or to be heteronucleated or diversely homonucleated in different structure models (reviewed in [20] ). The incorporation of Zn 2+ and Mn 2+ simultaneously, however, has neither been observed nor predicted in EhDbr1. We propose that the differing methods of metal removal and enrichment during or following purification could be a reason for the difference in active site metal composition we describe and the other published structures. Thus, considering the variability in both incorporated metal ions and associated substrate turnover rates, experiments probing the optimal metal ion requirements for the catalytic activity of EhDbr1 are ongoing.
